Cargando…

Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database

BACKGROUND: The optimal multimodality therapy for pancreatic ductal adenocarcinoma in the body or tail of the pancreas (PDAC-BT) is unclear. The purpose of this study was to compare overall 5-year survival between patients treated with adjuvant chemotherapy, adjuvant chemoradiation, and surgery alon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seaton, Max, Hanna, Andrew, Boutros, Cherif, Hanna, Nader
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501493/ https://www.ncbi.nlm.nih.gov/pubmed/31105777 http://dx.doi.org/10.1177/1758835919842438

Ejemplares similares

Defining the molecular pathology of pancreatic body and tail adenocarcinoma
Publicado: (2018)

Factors Affecting Adjuvant Therapy in Stage III Pancreatic Cancer—Analysis of the National Cancer Database
por: Krishnan, Mridula, et al.
Publicado: (2017)

A Rare Case of Pancreatic Tail Hydatid Cyst with Incidental Adenocarcinoma of the Pancreatic Body
por: Zarbaliyev, Elbrus, et al.
Publicado: (2019)

Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail
por: Matsui, Yuki, et al.
Publicado: (2022)

Tumors of the Pancreatic Body and Tail
por: Barreto, Savio George, et al.
Publicado: (2010)

Pancreatic head vs pancreatic body/tail cancer: Are they different?
por: Sun, Kai, et al.
Publicado: (2022)

Multivisceral resection for adenocarcinoma of the pancreatic body and tail—a retrospective single-center analysis
por: Beetz, Oliver, et al.
Publicado: (2020)

Dissimilar survival and clinicopathological characteristics of mucinous adenocarcinoma located in pancreatic head and body/tail
por: Li, Zheng, et al.
Publicado: (2023)

Melena as Initial Presentation of Adenocarcinoma in Pancreatic Tail
por: Pak, Stella, et al.
Publicado: (2017)

Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages
por: Zhang, Xueyou, et al.
Publicado: (2021)

Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study
por: Lof, Sanne, et al.
Publicado: (2019)

Clinical data combined with radiological imaging improves the accuracy of TNM staging of pancreatic body and tail adenocarcinoma
por: Xu, Wei, et al.
Publicado: (2017)

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

Early results on the use of biomaterials as adjuvant to abdominal wall closure following cytoreduction and hyperthermic intraperitoneal chemotherapy
por: Boutros, Cherif, et al.
Publicado: (2010)

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022)

Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis
por: Kamarajah, Sivesh K., et al.
Publicado: (2020)

Integrated analysis of metabolome in a EUS-FNA sample with transcriptome in the TCGA cohort of pancreatic head and body/tail adenocarcinoma
por: Ke, Chen, et al.
Publicado: (2021)

Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer Database
por: Shah, Mihir M., et al.
Publicado: (2020)

The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
por: Amin, Saber, et al.
Publicado: (2020)

Disparities in survival by stage after surgery between pancreatic head and body/tail in patients with nonmetastatic pancreatic cancer
por: Zheng, Zhenjiang, et al.
Publicado: (2019)

The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
por: Amin, Saber, et al.
Publicado: (2020)

Comparison of Invasive Pancreatic Ductal Adenocarcinoma versus Intraductal Papillary Mucinous Neoplasm: A National Cancer Database Analysis †
por: Ziogas, Ioannis A., et al.
Publicado: (2023)

Adjuvant, neoadjuvant, and experimental regimens in overcoming pancreatic ductal adenocarcinoma
por: Wysocka, Olga, et al.
Publicado: (2016)

Development of a Nomogram to Predict Disease-Specific Survival for Patients After Resection of a Non-Metastatic Adenocarcinoma of the Pancreatic Body and Tail
por: Zou, Yiping, et al.
Publicado: (2020)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
por: He, Chaobin, et al.
Publicado: (2020)

Late metachronous cerebral metastasis of pancreatic adenocarcinoma of the tail of the pancreas: a case report
por: Papadimitriou, Kyriakos, et al.
Publicado: (2022)

Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins
por: Patel, Ankur K., et al.
Publicado: (2020)

Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail
por: Sugimoto, Mitsuru, et al.
Publicado: (2018)

Distal pancreatectomy with en bloc celiac axis resection for pancreatic body-tail cancer: Is it justified?
por: Zhou, Yan-Ming, et al.
Publicado: (2014)

Distal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axis
por: Ham, Hyemin, et al.
Publicado: (2015)

Is There a Standard Adjuvant Therapy for Resected Pancreatic Cancer?
por: Fenocchio, Elisabetta, et al.
Publicado: (2019)

Impact of timing to initiate adjuvant therapy on survival of elderly glioblastoma patients using the SEER-Medicare and national cancer databases
por: Zhu, Ping, et al.
Publicado: (2023)

The Use and Benefit of Adjuvant Radiotherapy in Parathyroid Carcinoma: A National Cancer Database Analysis
por: Limberg, Jessica, et al.
Publicado: (2020)

Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
por: Lan, Xiaoyang, et al.
Publicado: (2023)

Commentary: Systemic adjuvant therapy for esophageal adenocarcinoma
por: Weksler, Benny
Publicado: (2021)

Management of Patients with Pancreatic Ductal Adenocarcinoma in the Real-Life Setting: Lessons from the French National Hospital Database
por: de la Fouchardière, Christelle, et al.
Publicado: (2021)

Radical resection of T1 pancreatic adenocarcinoma with a pseudocyst of the tail due to acute obstructive pancreatitis: report of a case
por: Fujiwara, Yuki, et al.
Publicado: (2016)

Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database
por: Nahleh, Zeina A, et al.
Publicado: (2020)

Neoadjuvant and Adjuvant Treatments for Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: The Current Status of Pancreatic Ductal Adenocarcinoma Treatment in Japan
por: Ei, Shigenori, et al.
Publicado: (2023)

Accessory spleen in pancreatic tail
por: George, Mark, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2hiiabv9vf6h4eg8t94hsjgg41